| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 89.9513 | 74 |
| GSM780708 | Untreated after 4 days (C2_1) | 96.6905 | 75 |
| GSM780709 | Untreated after 4 days (C3_1) | 103.858 | 76 |
| GSM780719 | Untreated after 4 days (C1_2) | 87.0557 | 73 |
| GSM780720 | Untreated after 4 days (C2_2) | 98.2561 | 75 |
| GSM780721 | Untreated after 4 days (C3_2) | 92.8119 | 74 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 86.3734 | 73 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 97.2774 | 75 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 76.6711 | 71 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 93.3751 | 74 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 97.0808 | 75 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 88.701 | 73 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 107.048 | 76 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 88.0198 | 73 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 92.9804 | 74 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 88.5631 | 73 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 80.7788 | 72 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 99.4533 | 75 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 122.534 | 78 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 103.919 | 76 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 99.9222 | 75 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 116.933 | 77 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 92.9296 | 74 |